These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23507417)

  • 1. Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions.
    Chung SJ; Armasu SM; Anderson KJ; Biernacka JM; Lesnick TG; Rider DN; Cunningham JM; Ahlskog JE; Frigerio R; Maraganore DM
    Parkinsonism Relat Disord; 2013 Jun; 19(6):595-9. PubMed ID: 23507417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?
    Biernacka JM; Armasu SM; Cunningham JM; Ahlskog JE; Chung SJ; Maraganore DM
    Parkinsonism Relat Disord; 2011 Dec; 17(10):730-6. PubMed ID: 21816655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common variants in PARK loci and related genes and Parkinson's disease.
    Chung SJ; Armasu SM; Biernacka JM; Lesnick TG; Rider DN; Lincoln SJ; Ortolaza AI; Farrer MJ; Cunningham JM; Rocca WA; Maraganore DM
    Mov Disord; 2011 Feb; 26(2):280-8. PubMed ID: 21412835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.
    Heckman MG; Elbaz A; Soto-Ortolaza AI; Serie DJ; Aasly JO; Annesi G; Auburger G; Bacon JA; Boczarska-Jedynak M; Bozi M; Brighina L; Chartier-Harlin MC; Dardiotis E; Destée A; Ferrarese C; Ferraris A; Fiske B; Gispert S; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lin CH; Lohmann K; Loriot MA; Lynch T; Mellick GD; Mutez E; Opala G; Park SS; Petrucci S; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Tomiyama H; Uitti RJ; Valente EM; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Xiromerisiou G; Maraganore DM; Farrer MJ; Ross OA;
    Neurobiol Aging; 2014 Jan; 35(1):266.e5-14. PubMed ID: 23962496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
    Boros FA; Török R; Vágvölgyi-Sümegi E; Pesei ZG; Klivényi P; Vécsei L
    Neurosci Lett; 2019 Jul; 706():140-145. PubMed ID: 31085292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
    Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
    Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease?
    Sutherland GT; Halliday GM; Silburn PA; Mastaglia FL; Rowe DB; Boyle RS; O'Sullivan JD; Ly T; Wilton SD; Mellick GD
    Mov Disord; 2009 Apr; 24(6):833-8. PubMed ID: 19224617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population.
    Trotta L; Guella I; Soldà G; Sironi F; Tesei S; Canesi M; Pezzoli G; Goldwurm S; Duga S; Asselta R
    Parkinsonism Relat Disord; 2012 Mar; 18(3):257-62. PubMed ID: 22104010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: a replication study in a Taiwanese cohort.
    Wu-Chou YH; Chen YT; Yeh TH; Chang HC; Weng YH; Lai SC; Huang CL; Chen RS; Huang YZ; Chen CC; Hung J; Chuang WL; Lin WY; Chen CH; Lu CS
    Parkinsonism Relat Disord; 2013 Feb; 19(2):251-5. PubMed ID: 23182315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.
    Elbaz A; Ross OA; Ioannidis JP; Soto-Ortolaza AI; Moisan F; Aasly J; Annesi G; Bozi M; Brighina L; Chartier-Harlin MC; Destée A; Ferrarese C; Ferraris A; Gibson JM; Gispert S; Hadjigeorgiou GM; Jasinska-Myga B; Klein C; Krüger R; Lambert JC; Lohmann K; van de Loo S; Loriot MA; Lynch T; Mellick GD; Mutez E; Nilsson C; Opala G; Puschmann A; Quattrone A; Sharma M; Silburn PA; Stefanis L; Uitti RJ; Valente EM; Vilariño-Güell C; Wirdefeldt K; Wszolek ZK; Xiromerisiou G; Maraganore DM; Farrer MJ;
    Ann Neurol; 2011 May; 69(5):778-92. PubMed ID: 21391235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head injury, potential interaction with genes, and risk for Parkinson's disease.
    Gao J; Liu R; Zhao E; Huang X; Nalls MA; Singleton AB; Chen H
    Parkinsonism Relat Disord; 2015 Mar; 21(3):292-6. PubMed ID: 25603768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease.
    Mata IF; Yearout D; Alvarez V; Coto E; de Mena L; Ribacoba R; Lorenzo-Betancor O; Samaranch L; Pastor P; Cervantes S; Infante J; Garcia-Gorostiaga I; Sierra M; Combarros O; Snapinn KW; Edwards KL; Zabetian CP
    Mov Disord; 2011 Apr; 26(5):819-23. PubMed ID: 21425343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease.
    Satake W; Nakabayashi Y; Mizuta I; Hirota Y; Ito C; Kubo M; Kawaguchi T; Tsunoda T; Watanabe M; Takeda A; Tomiyama H; Nakashima K; Hasegawa K; Obata F; Yoshikawa T; Kawakami H; Sakoda S; Yamamoto M; Hattori N; Murata M; Nakamura Y; Toda T
    Nat Genet; 2009 Dec; 41(12):1303-7. PubMed ID: 19915576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The age at motor symptoms onset in LRRK2-associated Parkinson's disease is affected by a variation in the MAPT locus: a possible interaction.
    Gan-Or Z; Bar-Shira A; Mirelman A; Gurevich T; Giladi N; Orr-Urtreger A
    J Mol Neurosci; 2012 Mar; 46(3):541-4. PubMed ID: 21898123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide association study confirms extant PD risk loci among the Dutch.
    Simón-Sánchez J; van Hilten JJ; van de Warrenburg B; Post B; Berendse HW; Arepalli S; Hernandez DG; de Bie RM; Velseboer D; Scheffer H; Bloem B; van Dijk KD; Rivadeneira F; Hofman A; Uitterlinden AG; Rizzu P; Bochdanovits Z; Singleton AB; Heutink P
    Eur J Hum Genet; 2011 Jun; 19(6):655-61. PubMed ID: 21248740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAPT IVS1+124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals.
    Dan X; Wang C; Ma J; Feng X; Wang T; Zheng Z; Chan P
    Neurobiol Aging; 2014 Jul; 35(7):1780.e7-1780.e10. PubMed ID: 24559644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians.
    Huang Y; Wang G; Rowe D; Wang Y; Kwok JB; Xiao Q; Mastaglia F; Liu J; Chen SD; Halliday G
    Biomed Res Int; 2015; 2015():135674. PubMed ID: 25960998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease age at onset genome-wide association study: Defining heritability, genetic loci, and α-synuclein mechanisms.
    Blauwendraat C; Heilbron K; Vallerga CL; Bandres-Ciga S; von Coelln R; Pihlstrøm L; Simón-Sánchez J; Schulte C; Sharma M; Krohn L; Siitonen A; Iwaki H; Leonard H; Noyce AJ; Tan M; Gibbs JR; Hernandez DG; Scholz SW; Jankovic J; Shulman LM; Lesage S; Corvol JC; Brice A; van Hilten JJ; Marinus J; ; Eerola-Rautio J; Tienari P; Majamaa K; Toft M; Grosset DG; Gasser T; Heutink P; Shulman JM; Wood N; Hardy J; Morris HR; Hinds DA; Gratten J; Visscher PM; Gan-Or Z; Nalls MA; Singleton AB;
    Mov Disord; 2019 Jun; 34(6):866-875. PubMed ID: 30957308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An exploratory analysis on gene-environment interactions for Parkinson disease.
    Gao J; Nalls MA; Shi M; Joubert BR; Hernandez DG; Huang X; Hollenbeck A; Singleton AB; Chen H
    Neurobiol Aging; 2012 Oct; 33(10):2528.e1-6. PubMed ID: 22763023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of gene discovery in Parkinson's disease and parkinsonism.
    Wider C; Foroud T; Wszolek ZK
    Mov Disord; 2010; 25 Suppl 1():S15-20. PubMed ID: 20187245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.